Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Schuster

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
Frontiers in Oncology|December 29, 2023
Lesion segmentation on <sup>18</sup>F-fluciclovine PET/CT images using deep learningTonghe Wang, Yang Lei, Eduard Schreibmann, et al.
The British Journal of Radiology|January 6, 2018
Bayesian penalised likelihood reconstruction (Q.Clear) of <sup>18</sup>F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluationEugene J Teoh, Daniel R McGowan, David M Schuster, et al.
Surgery|December 26, 2006
Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?Jyotirmay Sharma, Peter Mazzaglia, Mira Milas, et al.
Nuclear Medicine Communications|August 12, 2010
Posterior bladder layering of excreted 18F-FDG on PET/CTWanzhen Zeng, Julio N Sepulveda, Jonathan Nye, et al.
Proceedings of Spie--The International Society for Optical Engineering|September 24, 2016
Combining Population and Patient-Specific Characteristics for Prostate Segmentation on 3D CT ImagesLing Ma, Rongrong Guo, Zhiqiang Tian, et al.
Environmental and Molecular Mutagenesis|September 13, 2024
Power analyses to inform Duplex Sequencing study designs for MutaMouse liver and bone marrowElena Esina, Annette E Dodge, Andrew Williams, et al.
Nuclear Medicine Communications|December 11, 2020
Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancerBernard Cheng, Ila Sethi, Neena Davisson, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 28, 2014
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept studyNima Kokabi, James R Galt, Minzhi Xing, et al.
AJR. American Journal of Roentgenology|June 20, 2019
Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate CancerBital Savir-Baruch, Petra Lovrec, Abhishek A Solanki, et al.
EJNMMI Research|December 7, 2020
[<sup>18</sup>F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosisEphraim E Parent, Dhruv Patel, Jonathon A Nye, et al.
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|December 29, 2023
Lesion segmentation on <sup>18</sup>F-fluciclovine PET/CT images using deep learningTonghe Wang, Yang Lei, Eduard Schreibmann, et al.
The British Journal of Radiology|January 6, 2018
Bayesian penalised likelihood reconstruction (Q.Clear) of <sup>18</sup>F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluationEugene J Teoh, Daniel R McGowan, David M Schuster, et al.
Surgery|December 26, 2006
Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?Jyotirmay Sharma, Peter Mazzaglia, Mira Milas, et al.
Nuclear Medicine Communications|August 12, 2010
Posterior bladder layering of excreted 18F-FDG on PET/CTWanzhen Zeng, Julio N Sepulveda, Jonathan Nye, et al.
Proceedings of Spie--The International Society for Optical Engineering|September 24, 2016
Combining Population and Patient-Specific Characteristics for Prostate Segmentation on 3D CT ImagesLing Ma, Rongrong Guo, Zhiqiang Tian, et al.
Environmental and Molecular Mutagenesis|September 13, 2024
Power analyses to inform Duplex Sequencing study designs for MutaMouse liver and bone marrowElena Esina, Annette E Dodge, Andrew Williams, et al.
Nuclear Medicine Communications|December 11, 2020
Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancerBernard Cheng, Ila Sethi, Neena Davisson, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 28, 2014
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept studyNima Kokabi, James R Galt, Minzhi Xing, et al.
AJR. American Journal of Roentgenology|June 20, 2019
Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate CancerBital Savir-Baruch, Petra Lovrec, Abhishek A Solanki, et al.
EJNMMI Research|December 7, 2020
[<sup>18</sup>F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosisEphraim E Parent, Dhruv Patel, Jonathon A Nye, et al.
Pageof 18